World News | Agence France-Presse | Friday September 18, 2020
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency.
www.ndtv.com